Several publicly traded drug distributors are vying to buy Florida Cancer Specialists & Research Institute, a privately held operator of oncology clinics, people familiar with the matter said.
Florida Cancer Specialists may be valued at more than $3 billion in a deal, the people said, asking not to be identified because the matter is private. The company has been working with a financial adviser as it fields interest and explores a possible sale, they said.
Any ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.